890-38-0
890-38-0 结构式
基本信息
2ˊ-脱氧肌苷
9-(2-脱氧-Β-D-呋喃核糖基)次黄嘌呤
9-(2-DEOXY-BETA-D-RIBOFURANOSYL)HYPOXANTHINE
DEOXYINOSINE, 2'-
DI
2’-deoxy-inosin
Deoxyinosine
Hypoxanthine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-
9-(2-deoxy-β-d-ribofuranosyl)hypoxanthine
2'-Deoxy-D-inosine
9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
DEOXYINOSINE, 2'-(P)
2''-DEOXYINOSINE Crystalline
9-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydropurin-6-one
2-DEOXYINOSINE extrapure
9-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
Inosine, 2'-deoxy-
物理化学性质
知名试剂公司产品信息
2'-Deoxyinosine,>98.0%(LC)(T)(890-38-0)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/02/08 | HY-W008638 | 2'-脱氧肌苷 2'-Deoxyinosine | 890-38-0 | 50 mg | 300元 |
| 2025/02/08 | HY-W008638 | 2'-脱氧肌苷 2'-Deoxyinosine | 890-38-0 | 10mM * 1mLin DMSO | 330元 |
| 2025/02/08 | XW89038003 | 2’-脱氧肌苷 | 890-38-0 | 5G | 255元 |
常见问题列表
|
Human Endogenous Metabolite
|
In the absence of deoxycoformycin, 2’-deoxyadenosine is primarily deaminated to 2’-deoxyinosine and then converted into hypoxanthine. In the presence of the inhibitor, the deoxynucleoside, in addition to a phosphorylation process, undergoes phosphorolytic cleavage giving rise to adenine. The conversion of 2’-deoxyadenosine to adenine might represent a protective device, emerging when the activity of adenosine deaminase is reduced or inhibited. There is much evidence to indicate that the enzyme catalyzing this processs may be distinct from methylthioadenosine phosphorylase and S-adenosyl homocysteine hydrolase, which are the enzymes reported to be responsible for the formation of adenine from 28-deoxyadenosine in mammals.